$ADCT

ADC Therapeutics SA

NYSE · Healthcare · Pharmaceutical Preparations · Epalinges, Switzerland

ADCT chart

What traders are saying about $ADCT

Latest posts

ADC Therapeutics SA news

ADC Therapeutics SA key financials

USD2025202420232022
Revenue$81.4M$70.8M$69.6M$209.9M
Net income-$142.6M-$157.8M-$240.1M-$157.1M
Diluted EPS$-1.12$-1.62$-2.94$-2.01
Total assets (year end)$323.1M$322.0M$354.8M$490.9M
Cash and equivalents (year end)$261.3M$250.9M$278.6M$326.4M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About ADC Therapeutics SA

Ticker
ADCT (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Epalinges, Switzerland
Incorporated in
Switzerland
Fiscal year end
December 31
SEC CIK
1771910

Frequently asked questions

What exchange is ADC Therapeutics SA listed on?

ADC Therapeutics SA trades on the NYSE under the ticker symbol ADCT.

What industry is ADC Therapeutics SA in?

ADC Therapeutics SA is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is ADC Therapeutics SA headquartered?

ADC Therapeutics SA's business address on file with the SEC is in Epalinges, Switzerland.

When does ADC Therapeutics SA's fiscal year end?

ADC Therapeutics SA's fiscal year ends on December 31.

How much revenue did ADC Therapeutics SA report?

ADC Therapeutics SA reported $81.4M in revenue for calendar year 2025, according to its SEC filings.